ABSTRACT
We recently developed a high throughput T cell receptor ß chain (TCRß) sequencing-based approach to identifying and tracking donor-reactive T cells. To address the role of clonal deletion in liver allograft tolerance, we applied this method in samples from a recent randomized study, ITN030ST, in which immunosuppression withdrawal was attempted within 2 years of liver transplantation. We identified donor-reactive T cell clones via TCRß sequencing following a pre-transplant mixed lymphocyte reaction and tracked these clones in the circulation following transplantation in 3 tolerant and 5 non-tolerant subjects. All subjects showed a downward trend and significant reductions in donor-reactive TCRß sequences were detected post-transplant in 6 of 8 subjects, including 2 tolerant and 4 non-tolerant recipients. Reductions in donor-reactive TCRß sequences were greater than those of all other TCRß sequences, including 3rd party-reactive sequences, in all 8 subjects, demonstrating an impact of the liver allograft after accounting for repertoire turnover. Although limited by patient number and heterogeneity, our results suggest that partial deletion of donor-reactive T cell clones may be a consequence of liver transplantation and does not correlate with success or failure of early immunosuppression withdrawal. These observations underscore the organ- and/or protocol-specific nature of tolerance mechanisms in humans.
Subject(s)
Clonal Deletion/physiology , Immunosuppression Therapy , T-Lymphocytes/immunology , T-Lymphocytes/physiology , Humans , Liver Transplantation/adverse effects , Tissue Donors , Transplantation Tolerance/physiologyABSTRACT
Thymic positive and negative selection events generate a T-cell repertoire that is MHC restricted and self-tolerant. The number of T cells undergoing positive and negative selection in normal mice has never been firmly established. We generated mice that lack the proapoptotic molecule Bim (bcl2l11) together with a Nur77(GFP) transgene, which allowed the identification and enumeration of T cells that would normally undergo clonal deletion. Using this method, we report the striking observation that six times more cells undergo negative selection than complete positive selection. Seventy-five percent of the negatively selected cells are deleted at the double positive stage in the thymic cortex, compared with 25% at the single positive stage in the medulla. The fact that more thymocytes are highly reactive to MHC than are weakly reactive is inconsistent with a random model of recognition and suggests that T-cell recognition is MHC biased. Furthermore, Bim(-/-) mice had an increased number of GFP(hi) cells in the peripheral lymphoid tissue and a corresponding increase in antigen experienced or anergic cell phenotype. Our data also show that the CD4+ T cells that are clonally deleted experienced only slightly stronger T-cell receptor signaling than those that developed into regulatory T cells.
Subject(s)
Clonal Deletion/physiology , Histocompatibility Antigens/immunology , Models, Immunological , T-Lymphocytes, Regulatory/immunology , Thymus Gland/immunology , Animals , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/immunology , Bcl-2-Like Protein 11 , Membrane Proteins/genetics , Membrane Proteins/immunology , Mice , Mice, Knockout , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Nuclear Receptor Subfamily 4, Group A, Member 1/immunology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/immunologyABSTRACT
Organ deposition of autoantibodies against the noncollagenous-1 domain of the α3 chain of type IV collagen leads to severe kidney and lung injury in anti-glomerular basement membrane disease. The origin and regulation of these highly pathogenic autoantibodies remains unknown. Anti-α3(IV) collagen B lymphocytes are predicted to mature in vivo ignorant of target antigen because α3(IV) collagen expression is highly tissue restricted and pathogenic epitopes are cryptic. However, a recent analysis of an anti-α3(IV)NC1 collagen autoantibody transgenic mouse model revealed that developing B cells are rapidly silenced by deletion and editing in the bone marrow. To dissect the role of collagen as central tolerogen in this model, we determined B cell fate in autoantibody transgenic mice genetically lacking α3(IV) collagen. We found that absence of the tissue target autoantigen has little impact on the fate of anti-α3(IV)NC1 B cells. This implies a more complex regulatory mechanism for preventing anti-glomerular basement membrane disease than has been previously considered, including the possibility that a second antigen present in bone marrow engages and tolerizes anti-α3(IV)NC1 collagen B cells.
Subject(s)
Autoantibodies , B-Lymphocytes , Clonal Deletion/physiology , Collagen Type IV , Self Tolerance/immunology , Animals , Anti-Glomerular Basement Membrane Disease/genetics , Anti-Glomerular Basement Membrane Disease/immunology , Autoantibodies/immunology , Autoantibodies/metabolism , Autoantigens/genetics , Autoantigens/immunology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Collagen Type IV/deficiency , Collagen Type IV/immunology , Collagen Type IV/metabolism , Disease Models, Animal , Epitopes/genetics , Epitopes/immunology , Extracellular Matrix/immunology , Extracellular Matrix/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Models, AnimalABSTRACT
The strength of interaction between the antigenic peptide-loaded MHC (MHC/p) and the TCR determines T-cell fate in the thymus. A high avidity interaction between the TCR and the MHC/p induces apoptosis of self-reactive T cells (negative selection), whereas a moderate avidity interaction rescues thymocytes from apoptosis and permits further differentiation to mature T cells (positive selection). Leukocyte common antigen-related molecule (LAR), a receptor-like protein tyrosine phosphatase, is expressed on immature thymocytes, but its role in thymocyte differentiation has not yet been fully elucidated. We analyzed LAR-deficient mice and demonstrated that LAR deficiency affected the differentiation and expansion of immature thymocytes as well as positive and negative selection. Furthermore, LAR deficiency resulted in a lower Ca2+ response. The results indicate that LAR is an important modulator of TCR signaling that controls thymocyte differentiation.
Subject(s)
Lymphopoiesis/physiology , Receptor-Like Protein Tyrosine Phosphatases, Class 2/physiology , T-Lymphocyte Subsets/cytology , Animals , Antigens, CD/analysis , Clonal Deletion/physiology , Female , Male , Mice , Mice, Knockout , Mice, Transgenic , Receptor-Like Protein Tyrosine Phosphatases, Class 2/deficiency , Receptor-Like Protein Tyrosine Phosphatases, Class 2/genetics , Receptors, Antigen, T-Cell/immunologyABSTRACT
The proapoptotic proteins BAX and BAK constitute the mitochondrial apoptotic gateway that executes cellular demise after integrating death signals. The lethal BAK is kept in check by voltage-dependent anion channel 2 (VDAC2), a mammalian-restricted VDAC isoform. Here, we provide evidence showing a critical role for the VADC2-BAK complex in determining thymocyte survival in vivo. Genetic depletion of Vdac2 in the thymus resulted in excessive cell death and hypersensitivity to diverse death stimuli including engagement of the T cell receptor. These phenotypes were completely rescued by the concurrent deletion of Bak but not that of Bax. Thus, the VDAC2-BAK axis provides a mechanism that governs the homeostasis of thymocytes. Our study reveals a sophisticated built-in rheostat that likely fine-tunes immune competence to balance autoimmunity and immunodeficiency.
Subject(s)
Clonal Deletion/physiology , T-Lymphocytes/cytology , Voltage-Dependent Anion Channel 2/physiology , bcl-2 Homologous Antagonist-Killer Protein/physiology , Animals , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , Apoptosis/genetics , Apoptosis/physiology , Autoimmunity/genetics , Autoimmunity/physiology , CD3 Complex/immunology , Clonal Deletion/genetics , Dimerization , Female , Gene Knockout Techniques , Genotype , Ion Transport/genetics , Ion Transport/physiology , Male , Mice , Mice, Knockout , Mitochondrial Membranes/physiology , Thymus Gland/cytology , Voltage-Dependent Anion Channel 2/deficiency , Voltage-Dependent Anion Channel 2/genetics , bcl-2 Homologous Antagonist-Killer Protein/deficiency , bcl-2 Homologous Antagonist-Killer Protein/genetics , bcl-2-Associated X Protein/physiologyABSTRACT
The present review summarizes recent data on age-related thymic changes termed thymic involution, and highlights the putative role of perturbances in extrathymical and, possibly, intrathymical production of gonadal steroids and catecholamines in this process. Thymic involution has been envisaged as an extremely complex process involving multifactorial mechanisms along the bone marrow-thymic axis that accounts for the major manifestations of immunosenescence. These mechanisms include basic cell aging processes (for example, cell replication and programmed cell death) and processes unique to the immune system (such as generation of the T cell receptor repertoire and control of potentially autoreactive cells). Given that the onset of age-associated thymic involution coincides with the rise in gonadal steroid levels at puberty, a causal link between these events has been suggested. It has been shown that: (1) peripubertal gonadectomy causes substantial decrease in the level of noradrenaline in adult male and female thymus and (2) catecholamines, acting via alpha- and beta-adrenoceptor, produce suppressive effects on the thymic cellularity and production of both effector and regulatory T cells. Furthermore, the possibility that gonadal steroids contribute to thymic involution is discussed in this paper. In light of recent data indicating that effects of gonadal hormone deprivation on the thymic cellularity and function are long lasting but transitory, a putative role for the intrathymic sex steroid/catecholamine production in assuring the organ involution, under conditions of their limited supply by extrathymic sources, is also considered.
Subject(s)
Aging/physiology , Catecholamines/physiology , Gonadal Steroid Hormones/physiology , Lymphopoiesis/physiology , T-Lymphocyte Subsets/cytology , Thymus Gland/growth & development , Adolescent , Adult , Animals , Atrophy , Bone Marrow/immunology , Cellular Senescence , Clonal Deletion/physiology , Female , Humans , Immune Tolerance/physiology , Immunocompetence , Lymphopoiesis/immunology , Male , Mice , Mice, Knockout , Models, Biological , Puberty/immunology , Puberty/physiology , Rats , Receptors, Adrenergic/physiology , Receptors, Cell Surface/physiology , Stromal Cells/physiology , T-Lymphocyte Subsets/immunology , Thymus Gland/cytology , Thymus Gland/pathologyABSTRACT
B cells have been shown in various animal models to induce immunological tolerance leading to reduced immune responses and protection from autoimmunity. We show that interaction of B cells with naive T cells results in T cell triggering accompanied by the expression of negative costimulatory molecules such as PD-1, CTLA-4, B and T lymphocyte attenuator, and CD5. Following interaction with B cells, T cells were not induced to proliferate, in a process that was dependent on their expression of PD-1 and CTLA-4, but not CD5. In contrast, the T cells became sensitive to Ag-induced cell death. Our results demonstrate that B cells participate in the homeostasis of the immune system by ablation of conventional self-reactive T cells.
Subject(s)
Autoantigens/immunology , Autoimmunity/physiology , B-Lymphocytes/immunology , Clonal Deletion/physiology , Gene Expression Regulation/immunology , T-Lymphocytes/immunology , Animals , Antigens, CD/biosynthesis , Antigens, CD/genetics , Antigens, CD/immunology , Antigens, Differentiation/biosynthesis , Antigens, Differentiation/genetics , Antigens, Differentiation/immunology , Autoantigens/biosynthesis , B-Lymphocytes/metabolism , CD5 Antigens/biosynthesis , CD5 Antigens/genetics , CD5 Antigens/immunology , CTLA-4 Antigen , Cell Proliferation , Homeostasis/immunology , Mice , Mice, Transgenic , Programmed Cell Death 1 Receptor , T-Lymphocytes/metabolismABSTRACT
Intracellular signaling initiated by ligation of the TCR influences cell fate at multiple points during the lifespan of a T cell. This is especially evident during thymic selection, where the nature of TCR-dependent signaling helps to establish a MHC-restricted, self-tolerant T cell repertoire. The Src homology 2 domain-containing leukocyte-specific phosphoprotein of 76 kDa (SLP-76) adaptor protein is a required intermediate in multiple signaling pathways triggered by TCR engagement, several of which have been implicated in dictating the outcome of thymic selection (e.g., intracellular calcium flux and activation of ERK family MAPKs). To determine if thymocyte maturation and selection at later stages of development are sensitive to perturbations in SLP-76 levels, we analyzed these crucial events using several transgenic (Tg) lines of mice expressing altered levels of SLP-76 in the thymus. In Tg mice expressing low levels of SLP-76 in preselection thymocytes, the CD4:CD8 ratio in the thymus and spleen was skewed in a manner consistent with impaired selection and/or maturation of CD4+ thymocytes. Low SLP-76 expression also correlated with reduced CD5 expression on immature thymocytes, consistent with reduced TCR signaling potential. In contrast, reconstitution of SLP-76 at higher levels resulted in normal thymic CD5 expression and CD4:CD8 ratios in the thymus and periphery. It is curious that thymic deletion of TCR-Tg (HY) thymocytes was markedly impaired in both lines of Tg-reconstituted SLP-76-/- mice. Studies using chimeric mice indicate that the defect in deletion of HY+ thymocytes is intrinsic to the developing thymocyte, suggesting that maintenance of sufficient SLP-76 expression from the endogenous locus is a key element in the selection process.
Subject(s)
Adaptor Proteins, Signal Transducing/physiology , Clonal Deletion/physiology , Phosphoproteins/physiology , T-Lymphocyte Subsets/cytology , Thymus Gland/cytology , Adaptor Proteins, Signal Transducing/deficiency , Adaptor Proteins, Signal Transducing/genetics , Animals , CD4-Positive T-Lymphocytes/cytology , CD5 Antigens/analysis , CD8-Positive T-Lymphocytes/cytology , Cell Differentiation , Immunologic Memory , Mice , Mice, Congenic , Mice, Knockout , Mice, Transgenic , Phosphoproteins/deficiency , Phosphoproteins/genetics , Radiation Chimera , Receptors, Antigen, T-Cell, alpha-beta/analysis , Receptors, Antigen, T-Cell, gamma-delta/analysis , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/physiology , Signal Transduction/physiology , Spleen/cytologyABSTRACT
Thymic stromal lymphopoietin, a four helix-bundle cytokine, is expressed mainly by barrier epithelial cells and is a potent activator of several cell types, particularly myeloid dendritic cells. TSLP influences the outcome of interactions between dendritic cells and CD4+ thymocytes and T cells in many situations, such as the regulation of the positive selection of regulatory T cells, maintenance of peripheral CD4+ T cell homeostasis and induction of CD4+ T cell-mediated allergic inflammation.
Subject(s)
Cytokines/physiology , T-Lymphocyte Subsets/cytology , Animals , Cell Movement , Clonal Deletion/physiology , Cytokines/chemistry , Dendritic Cells/cytology , Dendritic Cells/immunology , Dermatitis, Atopic/immunology , Dermatitis, Atopic/pathology , Dimerization , Epithelial Cells/metabolism , Homeostasis , Humans , Hypersensitivity, Immediate/immunology , Hypersensitivity, Immediate/pathology , Immunoglobulins , Inflammation/immunology , Membrane Glycoproteins/physiology , Mice , OX40 Ligand , Receptors, Cytokine/physiology , Receptors, Interleukin-7/chemistry , Signal Transduction , Stromal Cells/metabolism , T-Lymphocyte Subsets/immunology , Thymus Gland/metabolism , Tumor Necrosis Factors/physiology , Thymic Stromal LymphopoietinABSTRACT
Thymic tissue has previously been considered a requirement for the generation of a functional and diverse population of human T cells. We report that fibroblasts and keratinocytes from human skin arrayed on a synthetic 3-dimensional matrix support the development of functional human T cells from hematopoietic precursor cells in the absence of thymic tissue. Newly generated T cells contained T cell receptor excision circles, possessed a diverse T cell repertoire, and were functionally mature and tolerant to self MHC, indicating successful completion of positive and negative selection. Skin cell cultures expressed the AIRE, Foxn1, and Hoxa3 transcription factors and a panel of autoantigens. Skin and bone marrow biopsies can thus be used to generate de novo functional and diverse T cell populations for potential therapeutic use in immunosuppressed patients.
Subject(s)
Cell Differentiation/physiology , Skin/cytology , T-Lymphocyte Subsets/cytology , Autoantigens/biosynthesis , Autoantigens/genetics , Cells, Cultured , Clonal Deletion/physiology , Forkhead Transcription Factors/biosynthesis , Forkhead Transcription Factors/deficiency , Forkhead Transcription Factors/genetics , HLA Antigens/immunology , Homeodomain Proteins/biosynthesis , Homeodomain Proteins/genetics , Humans , Ligands , Paired Box Transcription Factors/deficiency , Paired Box Transcription Factors/genetics , Receptors, Antigen, T-Cell/metabolism , Receptors, Notch/metabolism , Self Tolerance/physiology , Skin/immunology , T-Lymphocyte Subsets/immunology , Thymus Gland/cytology , Thymus Gland/immunology , Transcription Factors/biosynthesis , Transcription Factors/genetics , AIRE ProteinABSTRACT
Two novel transgenic (Tg) strains were created expressing hen egg-white lysozyme (HEL) in a pancreas-specific fashion. RmHP.111 mice had levels of HEL per cell similar to that of the established ILK-3 strain, while RmHP.117 mice had 10-fold lower levels (50,000 molecules per cell). When bred to 3A9 TCR Tg mice, negative selection occurred equally in all three double-Tg combinations, yet only ILK-3 x 3A9 and RmHP.111 x 3A9 mice became diabetic. Additionally, activated 3A9 cells readily transferred diabetes into ILK-3 or RmHP.111 mice, but only marginally into the RmHP.117 strain. In the peripancreatic lymph node, division of naive 3A9 cells was similar between RmHP.111 and RmHP.117 strains, but pancreatic APCs from RmHP.111 x 3A9 mice stimulated HEL-reactive cells to a much greater degree than those from RmHP.117 x 3A9 mice. In this model, diabetes was dependent upon both initial priming in the peripancreatic lymph node and subsequent presentation in the pancreas, with disease incidence predicted by the beta cell level of autoantigen.
Subject(s)
Autoantigens/metabolism , Diabetes Mellitus, Type 1/diagnosis , Islets of Langerhans/immunology , Animals , Antibodies/metabolism , Cell Line , Clonal Deletion/physiology , Diabetes Mellitus, Type 1/genetics , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/metabolism , Enzyme-Linked Immunosorbent Assay , Insulin/genetics , Islets of Langerhans/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Muramidase/genetics , Muramidase/metabolism , Predictive Value of Tests , Promoter Regions, Genetic , Rats , Receptors, Antigen, T-Cell/geneticsABSTRACT
Gammadelta T cells play critical roles in immune regulation, tumour surveillance and specific primary immune responses. Mature gammadelta cells derive from thymic precursors that also generate alphabeta T cells. Recent reports have highlighted the impact of the strength of signal received via the T cell receptor on T cell lineage commitment, and the importance of cross-talk between committed alphabeta thymocytes and bipotential progenitors for normal gammadelta T cell differentiation. Studies on T cell receptor-mediated selection of gammadelta cells have supported the view that these unconventional T cells are positively rather than negatively selected on cognate self antigen.
Subject(s)
Cell Differentiation/immunology , Receptors, Antigen, T-Cell, gamma-delta/immunology , T-Lymphocytes/immunology , Animals , Cell Differentiation/physiology , Clonal Deletion/immunology , Clonal Deletion/physiology , Humans , Membrane Proteins/physiology , Receptors, Notch , Signal Transduction/physiology , T-Lymphocytes/cytology , T-Lymphocytes/physiology , Thymus Gland/cytology , Thymus Gland/immunology , Thymus Gland/physiologyABSTRACT
BACKGROUND: 15-Lipoxygenase (15-LO) is a nonheme iron-containing enzyme that catalyzes the peroxidation of fatty acids. Herein, we studied the effect of 15-LO overexpression in the vascular endothelium on thymocyte apoptosis by evaluating thymuses from low-density lipoprotein receptor-deficient (LDL-RD) mice and LDL-RD/15-LO mice. Thymuses were evaluated by immunohistochemistry and by TUNEL whereas in vitro studies were carried out by employing freshly isolated thymocytes from the respective mice and evaluation of apoptosis by propidium iodide and annexin V cytometry. METHODS AND RESULTS: The apoptotic index in LDL-RD/15-LO mice was significantly higher than in the LDL-RD mice. In the thymic medulla the difference was smaller, although still significant. Freshly isolated thymus cells from LDL-RD/15-LO mice exhibited a higher rate of spontaneous cell death than controls. Incubation of thymus cells in the presence of the cell-permeable caspase-3 inhibitor DEVD-CMK resulted in a decrease in the frequency of apoptotic cells in LDL-RD/15-LO thymocytes, whereas no effect was evident in control thymocytes. The antioxidant N-acetylcysteine causes the increase in apoptosis in both groups. CONCLUSION: LDL-RD/15-LO mice exhibit increased thymocyte apoptosis both in vivo and in vitro. These findings may suggest a role for 15-LO in the natural selection of thymocytes.
Subject(s)
Arachidonate 15-Lipoxygenase/physiology , Clonal Deletion/physiology , Endothelium, Vascular/metabolism , T-Lymphocytes/cytology , Thymus Gland/cytology , Acetylcysteine/pharmacology , Animals , Antioxidants/pharmacology , Apoptosis , Arachidonate 15-Lipoxygenase/genetics , Caspase 3 , Caspase Inhibitors , Cells, Cultured/cytology , Cells, Cultured/drug effects , Cells, Cultured/enzymology , Cysteine Proteinase Inhibitors/pharmacology , Humans , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Oligopeptides/pharmacology , Receptors, LDL/deficiency , Receptors, LDL/genetics , Thymus Gland/blood supplyABSTRACT
Self-reactive B cells specific for ubiquitous membrane-bound autoantigens are eliminated in the bone marrow by two mechanisms of tolerance: receptor editing and clonal deletion. However, the relative contributions of clonal deletion and receptor editing to B cell tolerance in a polyclonal B cell population have not been established. Here we show that tolerance toward a membrane antigen-reactive B cell clone acts by receptor editing with very minimal cell loss. The capacity of receptor editing to rescue almost all autoreactive B cells from deletion relies on the availability of multiple joining light chain gene segments as substrate for secondary immunoglobulin light chain gene rearrangement and is independent of the affinity of the autoantigen and the presence of non-autoreactive B cells. Our data further suggest that clonal deletion is a default pathway that functions only when receptor editing has been exhausted.
Subject(s)
Antigens/immunology , B-Lymphocytes/immunology , Cell Membrane/immunology , Immune Tolerance/immunology , Receptors, Cell Surface/immunology , Animals , Antigens/metabolism , Autoantigens/immunology , B-Lymphocytes/metabolism , Cell Division/physiology , Cell Membrane/metabolism , Clonal Deletion/physiology , Immune Tolerance/physiology , Mice , Receptors, Cell Surface/metabolismABSTRACT
The impaired elimination of self-reactive T cells is one factor that contributes to autoimmunity. Although the mechanism of thymic negative selection has been studied for decades, recent data demonstrate that the mechanisms underlying this fundamental process remain extremely controversial. Nonetheless, new models such as the Aire-deficient mice have demonstrated the importance of thymic negative selection in autoimmune disease progression in mice and humans.
Subject(s)
Autoimmunity/immunology , Clonal Deletion/immunology , Animals , Apoptosis/immunology , Apoptosis/physiology , Autoimmunity/physiology , Clonal Deletion/physiology , Humans , Receptors, Tumor Necrosis Factor/physiology , Transcription Factors/immunology , Transcription Factors/physiology , Tumor Necrosis Factor-alpha/physiology , AIRE ProteinABSTRACT
Ramos-Burkitt lymphoma (Ramos-BL) B cell line is a neoplastic model of normal B cell selection by apoptosis at the germinal center site during maturation of the humoral immune response and can be triggered into apoptosis by cross-linking their surface antigen receptor with antibodies directed against immunoglobulin (Ig)M (anti-IgM) or by treating with the calcium ionophore ionomycin. We have recently demonstrated that anti-IgM and ionomycin trigger significant activation of caspase-3, -7 and -8 and for cleavage of the resident nuclear proteins poly(ADP-ribose) polymerase (PARP) and lamin B1 in Ramos-BL B cells, suggesting that these caspases may be localized to the nucleus as well as to the cytoplasm of Ramos-BL B cells. In order to examine this hypothesis further, we fractionated Ramos-BL B cells into their cytosolic and nuclear components and examined for expression of the endogenous proform and active large subunit of caspase-3; procaspase-3 and its active p17 large subunit were identified in both the cytosolic and nuclear fractions of Ramos-BL B cells. Immunofluorescence staining together with ordinary and confocal microscopy confirmed the observations that procaspase-3 immunoreactivity was clearly identified in the cytoplasm and nucleus while Fas ligand staining was localized to the cell surface and PARP immunoactivity to the nucleus, which were used as controls; procaspase-3 exhibited granular nuclear immunoreactivity whereas PARP displayed diffuse nuclear immunoreactivity; both of which was more intense in the internucleolar regions. Taken together, we now present evidence that procaspases and their active large subunits are found in both the cytoplasm and the nucleus and that procaspases localized not only in the cytoplasm but also in the nucleus are activated following application of apoptotic stimulus in Ramos-BL B cells.
Subject(s)
Apoptosis/physiology , B-Lymphocytes/metabolism , Burkitt Lymphoma/metabolism , Caspases/metabolism , Enzyme Precursors/metabolism , Antibodies, Anti-Idiotypic/metabolism , B-Lymphocytes/drug effects , Caspase 3 , Caspases/drug effects , Cell Nucleus/metabolism , Child, Preschool , Clonal Deletion/physiology , Cytoplasm/metabolism , Enzyme Precursors/drug effects , Histones/metabolism , Humans , Ionomycin/pharmacology , Ionophores/pharmacology , Lamin Type B/drug effects , Lamin Type B/metabolism , Male , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases , Proteins/drug effects , Proteins/metabolismABSTRACT
Intrathymic T cell development represents one of the best studied paradigms of mammalian development. Lymphoid committed precursors enter the thymus and the Notch1 receptor plays an essential role in committing them to the T cell lineages. The pre-T cell receptor (TCR), as an autonomous cell signaling receptor, commits cells to the alphabeta lineage while its rival, the gammadeltaTCR, is involved in generating the gammadelta lineage of T cells. Positive and negative selection of immature alphabetaTCR-expressing cells are essential mechanisms for generating mature T cells, committing them to the CD4 and CD8 lineages and avoiding autoimmunity. Additional lineages of alphabetaT cells, such as the natural killer T cell lineage and the CD25+ regulatory T cell lineage, are formed when the alphabetaTCR encounters specific ligands in suitable microenvironments. Thus, positive selection and receptor-instructed lineage commitment represent a hallmark of the thymus. Ectopically expressed organ-specific antigens contribute to thymic self-nonself discrimination, which represents an essential feature for the evolutionary fitness of mammalian species.
Subject(s)
Clonal Deletion/physiology , T-Lymphocytes/physiology , Thymus Gland/physiology , Animals , Humans , Mice , Receptors, Antigen, T-Cell/physiology , Signal Transduction/physiologyABSTRACT
Immature double positive (DP) thymocytes bearing a T cell receptor (TCR) that interacts with self-major histocompatibility complex (MHC) molecules receive signals that induce either their differentiation (positive selection) or apoptosis (negative selection). Furthermore, those cells that are positively selected develop into two different lineages, CD4 or CD8, depending on whether their TCRs bind to MHC class II or I, respectively. Positive selection therefore involves rescue from the default fate (death), lineage commitment, and progression to the single positive (SP) stage. These are probably temporally distinct events that may require both unique and overlapping signals. Work in the past several years has started to unravel the signaling networks that control these processes. One of the first pathways identified as important for positive selection was Ras and its downstream effector, the Erk mitogen-activated protein kinase (MAPK) cascade. In this review we examine the factors that connect the TCR to the Ras/Erk cascade in DP thymocytes, as well as what we know about the downstream effectors of the Ras/Erk cascade important for positive selection. We also consider the possible role of this cascade in CD4/CD8 lineage development, and the possible interactions of the Ras/Erk cascade with Notch during these cell fate determination processes.
Subject(s)
Clonal Deletion/physiology , Mitogen-Activated Protein Kinases/physiology , T-Lymphocytes/physiology , ras Proteins/physiology , Animals , Humans , Protein-Tyrosine Kinases/physiology , Receptors, Antigen, T-Cell/physiologyABSTRACT
Fetal thymic organ cultures of N15-transgenic RAG-2-/- H-2b mice on normal, beta-2 microglobulin (beta2M)-/- or transporter associated with antigen processing (rAP-1)-/- MHCl-deficient backgrounds were used to examine differentiation of thymocytes bearing a TCR specific for a viral peptide bound to H-2Kb. Strong agonists mediate negative selection in all mice whereas weak agonists are positively selecting in beta2MW-/- mice but negatively selecting on TAP-1-/- or normal backgrounds. Very weak agonists and very weak antagonists are generally without effect in beta2M-/- mice yet foster differentiation in TAP-1-/- animals. The 20-40-fold reduction in beta2M4-/- thymic H-2Kb surface expression suggests that the avidity of the TCR for peptide-MHCI accounts for these differences, consistent with effects of TCR density and individual thymic-peptide abundance in peptide-MHC complexes. TCR-self-MHC interaction dominates Kb-based selection, subtly modulated by peptides as revealed by X-ray crystallography.
Subject(s)
ATP-Binding Cassette Transporters/physiology , Clonal Deletion/physiology , Peptide Fragments/immunology , T-Lymphocyte Subsets/cytology , Thymus Gland/cytology , beta 2-Microglobulin/deficiency , ATP Binding Cassette Transporter, Subfamily B, Member 2 , Animals , Antigens, Viral/chemistry , Antigens, Viral/immunology , Crystallography, X-Ray , DNA-Binding Proteins/deficiency , H-2 Antigens/immunology , H-2 Antigens/metabolism , Hydrophobic and Hydrophilic Interactions , Ligands , Lymphocyte Count , Macromolecular Substances , Mice , Mice, Knockout , Mice, Transgenic , Models, Molecular , Organ Culture Techniques , Peptide Fragments/chemistry , Receptors, Antigen, T-Cell/immunology , Static Electricity , T-Lymphocyte Subsets/immunology , Vesicular stomatitis Indiana virus/immunologyABSTRACT
Major histocompatibility complex class II (MHCII) expression is regulated by the transcriptional coactivator CIITA. Positive selection of CD4(+) T cells is abrogated in mice lacking one of the promoters (pIV) of the Mhc2ta gene. This is entirely due to the absence of MHCII expression in thymic epithelia, as demonstrated by bone marrow transfer experiments between wild-type and pIV(-/-) mice. Medullary thymic epithelial cells (mTECs) are also MHCII(-) in pIV(-/-) mice. Bone marrow-derived, professional antigen-presenting cells (APCs) retain normal MHCII expression in pIV(-/-) mice, including those believed to mediate negative selection in the thymic medulla. Endogenous retroviruses thus retain their ability to sustain negative selection of the residual CD4(+) thymocytes in pIV(-/-) mice. Interestingly, the passive acquisition of MHCII molecules by thymocytes is abrogated in pIV(-/-) mice. This identifies thymic epithelial cells as the source of this passive transfer. In peripheral lymphoid organs, the CD4(+) T-cell population of pIV(-/-) mice is quantitatively and qualitatively comparable to that of MHCII-deficient mice. It comprises a high proportion of CD1-restricted natural killer T cells, which results in a bias of the V beta repertoire of the residual CD4(+) T-cell population. We have also addressed the identity of the signal that sustains pIV expression in cortical epithelia. We found that the Jak/STAT pathways activated by the common gamma chain (CD132) or common beta chain (CDw131) cytokine receptors are not required for MHCII expression in thymic cortical epithelia.